Latest Strategy News

Little Green Pharma has postponed the shareholder vote on issuing new shares tied to its Cannatrek acquisition, pushing the decision back a month to allow time to meet outstanding conditions. Other resolutions will proceed as planned on April 22.

Compumedics maintains robust sales momentum but faces FY26 revenue timing challenges due to MEG installation delays and a cautious Somfit D rollout. The company expects solid year-on-year growth and positions for improved execution in FY27.

Bass Oil’s March production faced Cooper Basin setbacks from heavy rains and storage limits, but trucking resumed in April with strong prices. Indonesian output remained steady with a sharp 47% price rise. The company is progressing its Vanessa gas field acquisition and Kiwi development with government backing.

Pure Resources has deepened its partnership with Rice University to develop carbon nanotube fibre thermal management technology aimed at AI and defence markets, leveraging its Garnet Hills graphite for a vertically integrated IP pipeline.

Caspin Resources has reported strong high-grade tin assay results from the first 11 holes of its 2026 drilling campaign at the Kelpie Deposit, part of the Bygoo Tin Project in NSW, confirming mineralisation beyond the current resource envelope and supporting potential resource growth.

Saturn Metals has divested its West Wyalong Gold Project interests to Xpedra Resources, receiving cash and shares, as it concentrates on advancing its flagship Apollo Hill Gold Project in Western Australia.

Lincoln Minerals (ASX:LML) has received all necessary approvals to begin a significant air core drilling program at its Minbrie Copper Project in South Australia, targeting 17km of prospective copper stratigraphy including 1.7km of untested strike at Eagle Ridge. The company plans at least 40 holes in Q2 2026 to identify key targets for follow-up drilling.

Tartana Minerals has closed a $275,000 share placement to its directors at a significant premium, issuing 5.5 million shares and promising options exercisable at 5.5 cents. The company also flagged imminent settlement of a larger $1.7 million placement from earlier this year.

Peninsula Energy (ASX: PEN) has voluntarily suspended trading of its shares pending a Supreme Court decision on the validity of share sales made earlier this year. The court hearing, set for 22 April, will determine if required disclosures were properly made for sales between February and April 2026.

Buru Energy has enhanced the Rafael Gas Project’s mid-case value by over 45% through new engineering insights, while securing A$5.3 million to advance development. The company delayed appraisal drilling to 2027 to optimise funding and project design, and navigates a leadership change with CEO Thomas Nador stepping down.

AdAlta, Oribiotech, and Cell Therapies have inked a Memorandum of Understanding to deploy Oribiotech’s IRO automated cell therapy manufacturing platform in Australia and Asia Pacific, aiming to slash costs and boost production speed for CAR-T therapies.

CDC Data Centres Australia has clinched its first public investment grade rating from Moody’s, unlocking fresh capital to expand its AI-focused data centre network amid surging demand.